SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending as investors discuss the potential impact of a signed $1.4 billion AI-powered data center contract, with some expressing frustration over the stock's current valuation relative to its peers and revenue projections. Community members are actively debating the reasons for the disconnect between the contract and the stock's performance, while also pointing to the company's AI technology and expansion plans.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending due to a significant surge following positive trial data and a "Breakthrough Therapy Designation" from the FDA, sparking excitement about the potential for a newly greenlighted drug. Community members are comparing SPRB to other high-flying stocks with similar float, while also cautioning against chasing the hype and creating bag holders. The stock's low float and backing from prominent investors are also being discussed as potential catalysts for further movement.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to new multi-year AI cloud contracts with top AI firms to deploy NVIDIA Blackwell GPUs, driving investor optimism about its strategic shift towards AI infrastructure. The community is actively discussing the company's potential for further growth, comparing it to other high-performing stocks, and speculating on future deal announcements. This momentum is supported by the broader context of increasing demand for AI infrastructure and data centers.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending due to an SEC probe into its data collection practices, sparking concerns about potential violations of platform agreements; the news has triggered a selloff. The community is debating the severity of the probe, with some viewing it as a buying opportunity amidst strong fundamentals, while others anticipate further downside. Analyst opinions remain divided, with some maintaining high price targets despite the recent volatility.

Siyata Mobile, Inc. engages in the provision of cellular communications systems for enterprise customers. It specializes in connected vehicle products for professional fleets, marketed under the Uniden Cellular and Siyata brands. The firm operates through the following geographical segments: Europe, the Middle East and Africa; Unites States; Canada; and Australia and New Zealand. The company was founded by Marc Seelenfreund on October 15, 1986 and is headquartered in Montreal, Canada.

Core AI Holdings Inc.

Core AI Holdings, Inc.

$CHAI (formerly $SYTA) is trending due to the finalized merger with Core Gaming, now trading under the new ticker. The community is actively discussing the impact of the reverse stock split and the company's new focus on AI-driven mobile gaming. Some traders are speculating on potential price movements and a possible short squeeze, while others are wary of the reverse split's effect.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid rumors of a potential tie-up with Tesla, sparked by a teaser video and fueling speculation about collaboration on autonomous flight. The community is actively discussing potential price targets and the likelihood of the partnership, with some emphasizing Archer's existing partnerships and growth potential in the eVTOL industry, while others express caution and highlight certification risks.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as investors react to news of Radical Semiconductor co-founders joining the company, fueling excitement around accelerated quantum-safe tech. Community chatter highlights the company's low market cap relative to its potential in the quantum security space, with some anticipating significant growth. The stock is gaining attention as a potentially undervalued play within the rapidly evolving quantum computing sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending due to speculation around potential U.S. government investment in its Greenland rare earth project, driving significant price volatility and high trading volume. Community discussions revolve around the validity of conflicting reports about government interest and the company's long-term potential in the rare earth element market. Some traders express bullish sentiment, citing the strategic importance of the Tanbreez project, while others are cautious, pointing to the company's financials and potential dilution.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors analyze the impact of their expanded agreement with Sanofi, focusing on future milestone payments and royalties. While some express excitement over the extended partnership and the potential for a Sanofi buyout, others are critical of the lack of immediate financial gains and continued delays in securing a CIC partnership. Discussions also revolve around vaccine availability and potential market share, especially given recent CDC recommendations.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following news of a partnership with Anthropic to enhance enterprise software development, with community members expressing excitement about the integration of Claude models and IBM's AI advancements. Bullish sentiment is fueled by the potential impact on IBM's products and the broader AI sector, with some viewing IBM as an undervalued tech giant poised for growth in quantum computing and AI-driven solutions. Discussions also involve IBM's partnerships with other companies like AMD and DVLT, highlighting its role in various tech innovations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates

VistaGen Therapeutics (VTGN) delivered earnings and revenue surprises of 0.00% and -62.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Exact Sciences (EXAS) Surpasses Q2 Earnings and Revenue Estimates

Exact Sciences (EXAS) delivered earnings and revenue surprises of +1,200.00% and +4.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?

Inovio (INO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Opus Genetics, Inc. (IRD) Reports Q1 Loss, Tops Revenue Estimates

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates

Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates

Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Tops Revenue Estimates

Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates...

Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update

Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025

Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA.

Vistagen Therapeutics Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$3.89
Prev Close	$3.65
Open	$3.65
Dividend Yield	0.00%
50-Day Moving Average	$3.24
Beta	1.46
Avg. Volume	534,958.48
PE Ratio	-2.45

52-Week High	$4.03
52-Week Low	$1.90
Market Capitalization	$119.35M
EPS (Annual)	-$1.67
Price to Book	2.01
Revenue Per Employee	$8,526.32
Enterprise Value/EBITDA	N/A

VTGN
VistaGen Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VTGN News

VTGN VistaGen Therapeutics Inc